• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Constant Therapeutics Announces First Patient Dosed in Phase 2 Trial of TXA127

    PR NEWSWIRE

    Constant Tx TXA127 To Enter NIH-Funded Clinical Trial At 60 Sites Around The US

    BIOSPACE

    Constant Therapeutics announces start of Phase 2 trial of peptide drug TXA127

    PRNEWSWIRE

    Constant announces start of Phase 2 trial of peptide drug TXA127 for COVID-19

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.